Omazif-CI

Calcium and Vitamin D3

Description

Description

Omazif-CI Capsule is the combined preparation of carbonyl iron, folic acid and zinc. It contains carbonyl iron with not less than 98% iron content. Carbonyl iron, having high bioavailability and low toxicity is safer and more effective choice for iron supplementation.

Composition Each capsule contains Carbonyl Iron USP equivalent to Elemental Iron 50 mg, Folic Acid BP 0.50 mg and Zinc Sulphate Monohydrate USP 61.80 mg equivalent to Elemental Zinc 22.50 mg.
Indications It is indicated for the treatment and prophylaxis of iron, folic acid and zinc deficiency especially during pregnancy and lactation.
Adult: one capsule daily before food or as directed by the physician.
Use of any drug during the first trimester of pregnancy should be avoided if possible. Thus administration of iron during the first trimester requires definite evidence of iron deficiency. Prophylaxis of iron deficiency where inadequate diet calls for supplementary zinc and folic acid is justified during the remainder of pregnancy.
Special care should be taken in patient with iron overload states, such as haemochromatosis, haemolyticanaemia or red cell aplasia. Failure to response to the treatment requires further investigations to exclude other causes of anaemia. In patients with renal failure there may be the risk of zinc accumulation.
Gastrointestinal irritations such as nausea, anorexia, vomiting, discomfort, constipation and diarrhoea may occur. Patients may complain of dark stool. Carbonyl iron pellets are incorporated into the capsules to reduce the possibility of gastrointestinal irritations. Rarely there may be allergic reactions.
Carbonyl iron may decrease the absorbption of tetracycline antibiotics, quinolone antibiotics, levodopa, levothyroxine, mrthyldopa and penecillamine. Folic acid interacts with antiepileptics, so plasma concentrations of phenobarbital, phenytoin and primidone are possibly reduced.
Gastrointestinal irritations such as nausea, anorexia, vomiting, discomfort, constipation and diarrhoea may occur. Patients may complain of dark stool. Carbonyl iron pellets are incorporated into the capsules to reduce the possibility of gastrointestinal irritations. Rarely there may be allergic reactions.
Symptoms of carbonyl iron include decreased energy, nausea, abdominal pain, tarry stool; a weak, rapid pulse, fever; coma; seizures.
Omazif-CI Capsule: Each box contains 6 blister of 10 capsules.